Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BORA: Phase 3 safety extension study of benralizumab in adults and adolescents with asthma on inhaled corticosteroid plus long-acting β2 agonist
2014-001086-27Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Sep 2014
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of benralizumab in asthma, sponsored by AstraZeneca. Started Sep 2014; status: completed.
02
Drugs
benralizumab
03
Conditions
asthma
Beyond the preview
Go deeper on 2014-001086-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001086-27.